This is getting nutty

This is getting nutty

Diabetic Investor is always on the lookout for groundbreaking news in the wacky world of diabetes. Whether it’s a way cool device that most patients won’t use or a new drug which is merely a copycat of already well-established drug, we want to know about it. We’re also on the lookout for studies that reveal new and vital information.  Study data is particularly interesting as the conclusions drawn by these studies often are the genesis for a new drug or new device. Many studies help physicians, Certified Diabetes Educators (CDE), pharmacists and other healthcare professionals offer better advice to their patients with diabetes. Diabetes is after all, a complex chronic disease with no one size fits all treatment regimens.

This is why we were so excited today when we learned that according to group of distinguished researchers from none other than Harvard University, walnut consumption lowered the risk for type 2 diabetes in women. (Frankly Diabetic Investor is surprised that a respected institution like Harvard would conduct any study with such a clear gender bias.) According to the study which was published in The Journal of Nutrition; “patients who consumed one to three servings (1 serving=28 g) of walnuts per month (HR=0.93; 95% CI, 0.88-0.99), one serving per week (HR=0.81; 95% CI, 0.70-0.94) and at least two servings per week (HR=0.67; 95% CI, 0.54-0.82) lowered their risk for type 2 diabetes compared with women who never or rarely consumed walnuts (P<.001).”

Now Diabetic Investor does not wish to cast any aspersions on this study nor do we wish to imply that the results were biased in any way but it should be noted that the study was funded by the California Walnut Commission. At least the authors properly disclosed this information which makes one really wonder why it is the Journal of Nutrition seems to have a higher set of standards than JAMA Internal Medicine, but alas we digress.

Truth be told, Diabetic Investor would have preferred another useless study on a subject which has bothered us for some time, the correlation between a woman’s breast size and diabetes. Results from previous studies on the subject, and no we are not joking as there have been studies on this subject, have been inconclusive. Unlike the debate over whether there is a casual relationship between GLP-1 usage and pancreatitis, which has been studied adnauseam, the debate over breast size and diabetes must be answered conclusively no matter how many studies need to be done. While obviously gender biased woman across the globe, their spouses, boyfriends or just friends with benefits are demanding a clear cut answer.

Looking at the recent Sports Illustrated swimsuit issue, we’re pretty sure that cover model Kate Upton wants to know whether she is at increased risk of developing diabetes.  Still a series of studies on the subject aren’t much good without a solution should it be learned that there really is a correlation between a woman’s breast size and diabetes. Given the diabetes device industry panache for throwing money into products which only a handful of patients will actually use and have little chance of being a commercial success Diabetic Investor can see this type of research resulting in a bra that doubles as a continuous glucose monitor. Think of it rather than having to wear a sensor that’s attached to their bodies wouldn’t it be great if the sensor could be built into a bra.

This is why research on things like walnuts eaten and risk of developing type 2 diabetes are worthless as what exactly will come of it. There are no devices we are aware of that measure walnut intake and glucose levels nor are we aware of any drugs made from walnuts. We suppose it is possible that the commercial angle here is a series of cookbooks and/or cable shows on how women can use walnuts with every meal and Diabetic Investor has the perfect host for just such a show, none other than Paula Dean. Ms. Dean is a perfect fit as she already has diabetes, knows something about cooking and has shown a propensity for doing anything that will make her a few more bucks.

So it looks we were wrong and some good might actually come from this useless study from our friends at Harvard. Wonder what they will study next. Rumor has it that the researchers looking to provide some balance to the diabetes debate will focus on a predominately male oriented issue, the association between beer drinking and diabetes. Although they would not confirm they were funding the study, sources tell Diabetic Investor that the Beer Institute which according to their web site, “The Beer Institute represents the $223 billion beer industry. An industry that includes more than 2,500 breweries and 1.8 million jobs” is working with Harvard. We can only imagine the commercial possibilities this research will yield.